Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Curevac N.V.
(NQ:
CVAC
)
3.250
-0.230 (-6.61%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 18, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,191,387
Open
3.470
Bid (Size)
3.150 (1)
Ask (Size)
3.330 (13)
Prev. Close
3.480
Today's Range
3.130 - 3.509
52wk Range
2.215 - 12.36
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Quantum Shares Are Trading Lower By 45%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Today 13:39 EDT
Via
Benzinga
First Human Death From Bird Flu Strain Puts Vaccine Stocks Back On The Map
June 06, 2024
Moderna shares are up almost 29% this month; CureVac is up 72% in the past month; and Novavax spiked 317% in the past month.
Via
Benzinga
Performance
YTD
-22.43%
-22.43%
1 Month
-4.41%
-4.41%
3 Month
+10.54%
+10.54%
6 Month
-20.73%
-20.73%
1 Year
-71.67%
-71.67%
More News
Read More
Ollie's Bargain Outlet Posts Upbeat Earnings, Joins Verint Systems, Guidewire Software And Other Big Stocks Moving Higher On Wednesday
June 05, 2024
Via
Benzinga
CureVac Announces Financial Results for the First Quarter of 2024 and Provides Business Update
May 23, 2024
Via
ACCESSWIRE
Why Lands' End Shares Are Trading Lower? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
June 05, 2024
Via
Benzinga
CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK
May 28, 2024
Via
ACCESSWIRE
Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
May 22, 2024
Via
Benzinga
Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
May 22, 2024
Via
Benzinga
Despegar.com Posts Strong Sales, Joins Reddit, Robinhood And Other Big Stocks Moving Higher On Friday
May 17, 2024
Via
Benzinga
CVAC Stock Earnings: CureVac Misses EPS, Misses Revenue for Q4 2023
May 15, 2024
Via
InvestorPlace
3 Stocks to Purge ASAP Before They’re Pulled off Life Support
May 10, 2024
Via
InvestorPlace
Elon Musk Breaks Ranks With GOP By Praising Genetic Engineering Tech That Helped Fight COVID-19: 'Digital Medicine With Incredible Potential'
May 09, 2024
Via
Benzinga
Spirit Airlines Posts Weak Results, Joins Integra LifeSciences, Bowlero And Other Big Stocks Moving Lower On Monday
May 06, 2024
Via
Benzinga
COVID-19 Patent Dispute Sorted: Acuitas Therapeutics and CureVac Reach Settlement In Patent Battle
April 26, 2024
Via
Benzinga
Topics
Intellectual Property
Lawsuit
Exposures
COVID-19
Financial
Intellectual Property
CureVac Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Business Update
April 24, 2024
Via
ACCESSWIRE
CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK
April 24, 2024
Via
ACCESSWIRE
CureVac Appoints Thaminda Ramanayake as New Chief Business Officer
April 24, 2024
Via
ACCESSWIRE
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
April 18, 2024
Via
ACCESSWIRE
CureVac and MD Anderson Enter Strategic Collaboration to Develop Novel Cancer Vaccines
April 16, 2024
Via
ACCESSWIRE
Bill Gates Called For A 'Universal Flu Vaccine,' Now The CDC Director Says The Organization Is 'Activated' After Issuing Bird Flu Alert
April 12, 2024
Via
Benzinga
CureVac, GS Partner Release Data On Influenza Vaccine Study
April 04, 2024
Via
Benzinga
CureVac Announces Promising Phase 2 Interim Data from Seasonal Influenza Vaccine Development Program in Collaboration with GSK
April 04, 2024
Via
ACCESSWIRE
Why Biopharmaceutical Player CureVac Shares Are Rising Today
January 05, 2024
Via
Benzinga
CureVac Announces Positive Phase 2 Interim Data from COVID-19 Vaccine Development Program in Collaboration with GSK Providing Strong Validation of Proprietary Technology Platform
January 05, 2024
Via
ACCESSWIRE
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 19, 2023
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.